Using an experimental medicine model to understand the antidepressant potential of the N-Methyl-D-aspartic acid (NMDA) receptor antagonist memantine

There is growing interest in the role of the glutamatergic system both in depression and as a novel target for treatments. Preclinical studies suggested that the non-competitive N-Methyl-D-aspartic acid (NMDA) receptor antagonist memantine might have antidepressant properties, but a randomised contr...

Descripción completa

Detalles Bibliográficos
Autores principales: Pringle, A, Parsons, E, Cowen, LG, McTavish, SF, Cowen, PJ, Harmer, CJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2012
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546643/
https://www.ncbi.nlm.nih.gov/pubmed/22596208
http://dx.doi.org/10.1177/0269881112446535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546643/
https://www.ncbi.nlm.nih.gov/pubmed/22596208
http://dx.doi.org/10.1177/0269881112446535

Ejemplares similares